TY - JOUR AU - Ferlay, J. AU - Soerjomataram, I. AU - Dikshit, R. AU - Eser, S. AU - Mathers, C. AU - Rebelo, M. PY - 2015 DA - 2015// TI - Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 JO - Int J Cancer VL - 136 UR - https://doi.org/10.1002/ijc.29210 DO - 10.1002/ijc.29210 ID - Ferlay2015 ER - TY - JOUR AU - Kobayashi, E. AU - Ueda, Y. AU - Matsuzaki, S. AU - Yokoyama, T. AU - Kimura, T. AU - Yoshino, K. PY - 2012 DA - 2012// TI - Biomarkers for screening, diagnosis, and monitoring of ovarian cancer JO - Cancer Epidemiol Biomarkers Prev VL - 21 UR - https://doi.org/10.1158/1055-9965.EPI-12-0646 DO - 10.1158/1055-9965.EPI-12-0646 ID - Kobayashi2012 ER - TY - JOUR AU - Lowe, K. A. AU - Chia, V. M. AU - Taylor, A. AU - O’Malley, C. AU - Kelsh, M. AU - Mohamed, M. PY - 2013 DA - 2013// TI - An international assessment of ovarian cancer incidence and mortality JO - Gynecol Oncol VL - 130 UR - https://doi.org/10.1016/j.ygyno.2013.03.026 DO - 10.1016/j.ygyno.2013.03.026 ID - Lowe2013 ER - TY - JOUR AU - Sedlakova, I. AU - Vavrova, J. AU - Tosner, J. AU - Hanousek, L. PY - 2011 DA - 2011// TI - Lysophosphatidic acid (LPA)-a perspective marker in ovarian cancer JO - Tumour Biol VL - 32 UR - https://doi.org/10.1007/s13277-010-0123-8 DO - 10.1007/s13277-010-0123-8 ID - Sedlakova2011 ER - TY - JOUR AU - Fang, X. AU - Schummer, M. AU - Mao, M. AU - Yu, S. AU - Tabassam, F. H. AU - Swaby, R. PY - 2002 DA - 2002// TI - Lysophosphatidic acid is a bioactive mediator in ovarian cancer JO - Biochim Biophys Acta VL - 1582 UR - https://doi.org/10.1016/S1388-1981(02)00179-8 DO - 10.1016/S1388-1981(02)00179-8 ID - Fang2002 ER - TY - JOUR AU - Smicun, Y. AU - Reierstad, S. AU - Wang, F. Q. AU - Lee, C. AU - Fishman, D. A. PY - 2006 DA - 2006// TI - S1P regulation of ovarian carcinoma invasiveness JO - Gynecol Oncol VL - 103 UR - https://doi.org/10.1016/j.ygyno.2006.06.036 DO - 10.1016/j.ygyno.2006.06.036 ID - Smicun2006 ER - TY - JOUR AU - Wang, F. Q. AU - Ariztia, E. V. AU - Boyd, L. R. AU - Horton, F. R. AU - Smicun, Y. AU - Hetherington, J. A. PY - 2010 DA - 2010// TI - Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity JO - Gynecol Oncol VL - 117 UR - https://doi.org/10.1016/j.ygyno.2009.12.012 DO - 10.1016/j.ygyno.2009.12.012 ID - Wang2010 ER - TY - JOUR AU - Aoki, J. PY - 2004 DA - 2004// TI - Mechanisms of lysophosphatidic acid production JO - Semin Cell Dev Biol VL - 15 UR - https://doi.org/10.1016/j.semcdb.2004.05.001 DO - 10.1016/j.semcdb.2004.05.001 ID - Aoki2004 ER - TY - JOUR AU - Aoki, J. AU - Inoue, A. AU - Okudaira, S. PY - 1781 DA - 1781// TI - Two pathways for lysophosphatidic acid production JO - Biochim Biophys Acta VL - 2008 ID - Aoki1781 ER - TY - JOUR AU - Luquain, C. AU - Singh, A. AU - Wang, L. AU - Natarajan, V. AU - Morris, A. J. PY - 2003 DA - 2003// TI - Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells JO - J Lipid Res VL - 44 UR - https://doi.org/10.1194/jlr.M300188-JLR200 DO - 10.1194/jlr.M300188-JLR200 ID - Luquain2003 ER - TY - JOUR AU - Bese, T. AU - Barbaros, M. AU - Baykara, E. AU - Guralp, O. AU - Cengiz, S. AU - Demirkiran, F. PY - 2010 DA - 2010// TI - Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer JO - J Gynecol Oncol VL - 21 UR - https://doi.org/10.3802/jgo.2010.21.4.248 DO - 10.3802/jgo.2010.21.4.248 ID - Bese2010 ER - TY - JOUR AU - Wang, D. L. AU - Chen, L. X. AU - Liao, X. L. AU - Liao, X. J. AU - Wu, Q. H. PY - 2013 DA - 2013// TI - The relationship of lysophosphatidic acid and MMP-2 in diagnosing epithelial ovarian carcinoma JO - Proc Clin Med VL - 22 ID - Wang2013 ER - TY - JOUR AU - Ding, F. AU - Niu, B. PY - 2013 DA - 2013// TI - Clinical significance of detecting lysophosphatidic acid and vascular endothelial growth factor in patients with epithelial ovarian carcinoma JO - Practical J Med Pharmacy VL - 30 ID - Ding2013 ER - TY - JOUR AU - Murph, M. AU - Tanaka, T. AU - Pang, J. AU - Felix, E. AU - Liu, S. AU - Trost, R. PY - 2007 DA - 2007// TI - Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis JO - Methods Enzymol VL - 433 UR - https://doi.org/10.1016/S0076-6879(07)33001-2 DO - 10.1016/S0076-6879(07)33001-2 ID - Murph2007 ER - TY - JOUR AU - Cao, X. Y. PY - 2008 DA - 2008// TI - The applicable value of combined detection of LPA, CA1 25 and AFP in the early diagnosis of ovarian cancer JO - Laboratory Med Clinic VL - 5 ID - Cao2008 ER - TY - JOUR AU - Jackson, D. AU - White, I. R. AU - Riley, R. D. PY - 2012 DA - 2012// TI - Quantifying the impact of between-study heterogeneity in multivariate meta-analyses JO - Stat Med VL - 31 UR - https://doi.org/10.1002/sim.5453 DO - 10.1002/sim.5453 ID - Jackson2012 ER - TY - JOUR AU - Peters, J. L. AU - Sutton, A. J. AU - Jones, D. R. AU - Abrams, K. R. AU - Rushton, L. PY - 2006 DA - 2006// TI - Comparison of two methods to detect publication bias in meta-analysis JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.6.676 DO - 10.1001/jama.295.6.676 ID - Peters2006 ER - TY - JOUR AU - Zintzaras, E. AU - Ioannidis, J. P. PY - 2005 DA - 2005// TI - HEGESMA: genome search meta-analysis and heterogeneity testing JO - Bioinformatics VL - 21 UR - https://doi.org/10.1093/bioinformatics/bti536 DO - 10.1093/bioinformatics/bti536 ID - Zintzaras2005 ER - TY - JOUR AU - Pozlep, B. AU - Meleh, M. AU - Kobal, B. AU - Verdenik, I. AU - Osredkar, J. AU - Kralj, L. Z. PY - 2007 DA - 2007// TI - Use of lysophosphatidic acid in the management of benign and malignant ovarian tumors JO - Eur J Gynaecol Oncol VL - 28 ID - Pozlep2007 ER - TY - JOUR AU - Zhang, Y. M. AU - Zhang, X. N. PY - 2007 DA - 2007// TI - Expression of XIAP, Survivin, LPA and CA12 5 in human epithelial ovarian carcinoma JO - Journal of Shandong University (Health Science) VL - 45 ID - Zhang2007 ER - TY - JOUR AU - Yan, Z. T. AU - Huang, N. AU - Zhao, M. L. AU - Pang, A. P. PY - 2009 DA - 2009// TI - Clinical Values of serum CA125 and LPA determination in early diagnosis of ovarian cancer JO - Chinese Journal of Primary Medicine and Pharmacy VL - 16 ID - Yan2009 ER - TY - JOUR AU - Xu, Y. AU - Shen, Z. AU - Wiper, D. W. AU - Wu, M. AU - Morton, R. E. AU - Elson, P. PY - 1998 DA - 1998// TI - Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.8.719 DO - 10.1001/jama.280.8.719 ID - Xu1998 ER - TY - JOUR AU - Wang, H. AU - Chen, D. Z. PY - 2008 DA - 2008// TI - Study on the diagnostic Value of Plasm a Lysopho sphatidic Acid (LPA) Level Determination in Patients with Ovarian Carcinoma JO - Journal of Radioimmunology VL - 21 ID - Wang2008 ER - TY - JOUR AU - Liao, J. R. AU - Zong, J. H. AU - Lv, Y. Y. PY - 2010 DA - 2010// TI - Detection of Plasma Iysophosphatidic Acid (LPA) in Epithelial Ovarian Tumor Patients JO - Inner Mongolia Medical Journal VL - 42 ID - Liao2010 ER - TY - JOUR AU - Liang, H. F. AU - Zhang, H. AU - Ma, X. Y. PY - 2011 DA - 2011// TI - Comparative analysis of the value of lysophosphatidic acid and CA125 in the diagnosis of ovarian cancer JO - Clinical Medicine of China VL - 27 ID - Liang2011 ER - TY - JOUR AU - Lian, X. F. AU - Li, X. L. AU - Zhan, H. L. AU - Sun, F. PY - 2010 DA - 2010// TI - The diagnostic value when lysophospholipids acid, epididymis protein 4 used in early ovarian cancer’ s detection JO - International Medicine and Health Guidance News VL - 16 ID - Lian2010 ER - TY - JOUR AU - Li, C. AU - Fang, S. H. AU - Chen, W. PY - 2007 DA - 2007// TI - The diagnostic value of sol uble P185 in ovarian cancer JO - Chinese Journal of Laboratory Diagnosis VL - 11 ID - Li2007 ER - TY - JOUR AU - Lao, M. AU - Pan, Z. M. AU - Huang, W. C. AU - Huang, L. S. AU - Zhu, B. AU - Zhao, H. L. PY - 2007 DA - 2007// TI - The value of plasma lysophosphatidic acid measurement in the diagnosis of gynecology tumor JO - The Practical Journal of Cancer VL - 22 ID - Lao2007 ER - TY - JOUR AU - Guo, H. Y. AU - Han, J. S. AU - Wu, Q. Z. AU - Yang, C. S. PY - 2002 DA - 2002// TI - A study of diagnostic value of plasma lysophosphatidic acid for ovarian epithelial cancer JO - Chinese Journal of Clinical Obstetrics and Gynecology VL - 03 ID - Guo2002 ER - TY - JOUR AU - Duan, M. L. AU - Wu, F. PY - 2005 DA - 2005// TI - The diagnostic value of secretory phospholipase A2 and lysophosphatic acid for ovarian cancer JO - Chinese Journal of Laboratory Medicine VL - 28 ID - Duan2005 ER - TY - JOUR AU - Du, Y. PY - 2005 DA - 2005// TI - Study on correlation between diagnosis of epithlial ovarian cancer and plasma lysophosphatidic acid JO - Zhejiang Medical Journal VL - 27 ID - Du2005 ER - TY - JOUR AU - Chen, Y. N. AU - Tao, M. AU - Tu, F. P. AU - Zuo, Y. AU - Lu, W. D. PY - 2008 DA - 2008// TI - LPA, IL-6 and IL-8 levels in the plasma of patients with epithelial ovarian carcinoma JO - The Practical Journal of Cancer VL - 23 ID - Chen2008 ER - TY - JOUR AU - Hu, Y. L. AU - Albanese, C. AU - Pestell, R. G. AU - Jaffe, R. B. PY - 2003 DA - 2003// TI - Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/95.10.733 DO - 10.1093/jnci/95.10.733 ID - Hu2003 ER - TY - JOUR AU - Hu, Y. L. AU - Tee, M. K. AU - Goetzl, E. J. AU - Auersperg, N. AU - Mills, G. B. AU - Ferrara, N. PY - 2001 DA - 2001// TI - Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells JO - J Natl Cancer Inst VL - 93 UR - https://doi.org/10.1093/jnci/93.10.762 DO - 10.1093/jnci/93.10.762 ID - Hu2001 ER - TY - JOUR AU - Nakamura, K. AU - Igarashi, K. AU - Ohkawa, R. AU - Yokota, H. AU - Masuda, A. AU - Nakagawa, S. PY - 2012 DA - 2012// TI - Serum autotaxin is not a useful biomarker for ovarian cancer JO - Lipids VL - 47 UR - https://doi.org/10.1007/s11745-012-3691-0 DO - 10.1007/s11745-012-3691-0 ID - Nakamura2012 ER -